Thursday, April 23, 2009: 11:15 AM-12:15 PM
Indigo Ballroom DH (Hilton San Diego Bayfront)
Functional Polymorphisms in Oxidant Metabolism and DNA Repair Pathways and Risk of Leukemia and Transient Myeloproliferative Disorder in Children with Down Syndrome
Melissa S. Rayburg, Mi-Ok Kim, PhD, Todd Alonzo, PhD, Robert Gerbing, Gretchen Radloff, Stella Davies, MBBS, PhD, MRCP, Alan S. Gamis, MD, MPH and John Perentesis, MD
Antisense Technology Targeting An Anti-Apoptotic Gene Improves Leukemic Cell Death in ALL Cell Lines and Mice
Laura E. Hogan, MD, David T. Teachey, MD, Nicole Germino, Naomi Moskowitz, MD, Gregory Condos, Ilana Belitskaya-Levy, PhD, Jinhua Wang, PhD, Deepa Bhojwani, MD, Terzah M. Horton, MD/PhD, Puja Sapra, Ivan Horak, Elizabeth Raetz, MD, Stephan A. Grupp, MD, PhD, William Carroll, MD and Debra Morrison, PhD
A Custom Quantitative Real Time PCR Minimal Residual Disease (MRD) Assay Predicts Outcome in MLL-Rearranged (MLL-R) Infant ALL: a Children's Oncology Group Study
Eric S. Schafer, MD, Kathleen M. Murphy, PhD, Kathleen Burns, MD, PhD, Emily McIntyre, MS, Michael J. Borowitz, MD/Ph.D, Stephen P. Hunger, MD, Brent Wood, MD, PhD, Andrew Carroll, PhD, Nyla Heerema, PhD, Richard Harvey, PhD, Cheryl L. Willman, MD, Zoann Dreyer, MD, Meenakshi Devidas, PhD and Patrick Brown, M.D.
Retroviral Insertional Mutagenesis Identifies Genes that Collaborate withCALM-AF10 to Induce Leukemia
David P. Harper, MD, David Caudell, DVM, PhD, Rachel L. Novak, PhD, Rachel M. Pierce, BS, Christopher Slape, PhD, Linda Wolff, PhD and Peter D. Aplan, MD